VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 2, 2011) - Abattis Biologix Corporation ("Abattis" or the "Company") has concluded a series of meetings and negotiations culminating in the signing of a number of strategically important asset purchase agreements and a letter of intent with various parties. Additionally, the Company wishes to announce changes to its Board of Directors. (7 hours ago)
↧